📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. (2013)

First Author: McClements L

Attributed to: Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-13-0595

PubMed Identifier: 23741069

Publication URI: http://europepmc.org/abstract/MED/23741069

Type: Journal Article/Review

Volume: 19

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 14

ISSN: 1078-0432